The Keto diet promotes weight loss while also raising cholesterol levels

On the keto diet, most of your calories come from fat.

Shutterstock/George Dolgic

The keto diet, which gets most of its calories from fat and few from carbohydrates, can certainly lead to fat loss, but it can also clog arteries and harm your gut flora.

Also known as the ketogenic diet, this diet forces your body to use a different type of fuel. Instead of relying on glucose from carbohydrates, you rely on ketones, a type of fuel your liver produces from your fat stores, which can lead to weight loss.

In previous studies, Comparing people who follow a ketogenic diet to those who don't suggests there are both advantages and disadvantages.

now, Javier Gonzalez Researchers at the University of Bath in the UK conducted the largest randomized controlled trial in medical evidence. They recruited 53 non-obese people with an average age of 34. They randomly assigned about one-third of them to a ketogenic diet, in which less than 8% of energy came from total carbohydrates and more than 70% came from fat.

The remaining third of participants were instructed to follow a low-carbohydrate diet, with 5 percent of their energy intake coming from 'free' sugars – a type of carbohydrate found in foods such as syrup, cakes and biscuits – and 45 percent and 35 percent from other carbohydrates and fat respectively.

The remaining third consumed diets with moderate amounts of free sugars, accounting for just under 20% of their energy intake, while carbohydrate and fat intakes without free sugars were around 30% and 35%, respectively. These participants acted as the control group. Protein intake was between 15-18% across all diets.

After one month, x-rays showed that participants on the ketogenic diet had lost an average of 1.6 kg of fat. The researchers verified that participants were following the diet by measuring ketone levels in their blood, urine, and breath. Food diaries also assessed adherence to the diet.

Meanwhile, those on low-carb diets lost an average of one kilogram of fat, while those on moderate diets lost nothing. By having participants intermittently wear activity monitors to estimate their energy intake, the team found that the fat loss was due to reduced calorie intake, not increased activity, something that hadn't been known before, Gonzalez says.

But despite greater fat loss, the ketogenic diet group had 16 percent higher levels of “bad” low-density lipoprotein (LDL) cholesterol than the control group, and 26 percent higher levels of apolipoprotein B, a protein that clogs arteries and increases the risk of heart-related events. In contrast, people on the low-carb diet had 10 percent lower LDL cholesterol levels than the control group, and no change in apolipoprotein B levels.

The researchers also found that people on a ketogenic diet had lower levels of a type of gut bacteria than those on a moderately low-carb diet. Bifidobacteriawhich Helps produce vitamin B and It has been shown to strengthen the immune systemThe same wasn't true for those on a low-carb diet, likely because those on the ketogenic diet consumed less fiber. Bifidobacteria Level, Gonzalez says.

However, it is unclear whether the ketogenic diet truly has a negative effect on the gut microbiome, because we do not fully know what the optimal diet is or what the full effects of the ketogenic diet are. Bifidobacteria says Natasha Scholer At Great Ormond Street Hospital in London.

Additionally, while elevated apolipoprotein B levels are a concern, the elevated cholesterol levels seen in the study aren't necessarily harmful unless they reach a dangerous threshold, Scholer said.

Longer-term studies are also needed to determine whether the weight-loss benefits of ketogenic diets outweigh potential concerns about cholesterol and gut health in obese people, Scholer said.

Ultimately, the main challenge for obese or overweight people to lose weight is following a diet, says Scholer: “Whether it's a normal carbohydrate diet, a low-calorie diet, or a calorie-for-calorie reduced-carb diet, if you stick to it, you will generally lose weight.”

topic:

Source: www.newscientist.com

Keto diet aids in sustaining weight loss post-Ozempic discontinuation

Ketogenic diet may help prevent weight gain

Shutterstock / Brent Hofacker

Type 2 diabetics who have stopped taking weight loss drugs such as Ozempic or Wegovy can avoid regaining lost weight by adopting a ketogenic diet. This finding from a small study challenges the concept that people must take these drugs indefinitely to prevent unwanted weight gain.

Ozempic and Wegovy belong to a class of drugs called GLP-1 agonists, which reduce appetite and stimulate the release of insulin. These are commonly prescribed to help people with type 2 diabetes regulate their blood sugar and lose weight. However, the assumption was that people would have to continue taking the drug over a long period of time or they would regain the weight they had lost.

Shaminy Athinarayanan The woman and her colleagues at Virta Health, a US telemedicine company that treats type 2 diabetes, decided to test that assumption. Their inspiration to do so came from previous research showing that low-carbohydrate diets like the ketogenic diet help people with type 2 diabetes manage blood sugar levels and weight.

Researchers tracked the weight and blood sugar levels of 308 adults with type 2 diabetes living in the United States who received nutritional therapy at Virta Health. They were all using GLP-1 agonists at enrollment. Participants were advised to follow a ketogenic diet. They were instructed to eat less than 30 grams of carbohydrates each day, or less than 50 grams if vegan, and about 1.5 grams of protein per kilogram of body weight each day. They were encouraged to eat until they were full, regardless of calories. Health coaches and qualified medical professionals communicated virtually with participants as needed.

After 3 to 9 months, half of the participants stopped using the GLP-1 agonist. All participants continued on the ketogenic diet for an additional year. At this point, the researchers found no significant differences in body weight or blood sugar levels between the two groups. On average, participants who stopped taking GLP-1 agonists gained only about 1 kg. In contrast, those who continued taking the drug gained about 2 kg. Most participants in both groups had blood sugar levels below the diagnostic criteria for diabetes.

“This study suggests that continued use of GLP-1 agonists is not necessary for many people if: [they] Appropriate intervention is required,” says Athinarayanan. “You can stop. [these medications] Maintain weight and blood sugar levels safely and effectively. ”

It says this could be helpful for people who can’t take the drug due to shortages or side effects. priya jaisinghani At New York University Langone Health. But she says people should talk to their doctor before starting a low-carb diet, as there can be risks, especially for people with underlying health conditions like kidney disease or eating disorders. He also noted that the study was sponsored by Virta Health and had a small number of participants. So “this is not the be all and end all,” Jaisinghani said. “But it shows the difference that diet makes.”

topic:

Source: www.newscientist.com